CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net Loss	$ (1,540,272)	$ (48,488)
Adjustments to reconcile net loss to net cash used in by operating activities -
Gain on reevaluation of contingent earn-out liability	0	(142,960)
Depreciation and amortization	156,586	157,460
Stock-based compensation expense	749,391	769,790
Non-cash interest expense	13,128	8,906
Changes in operating assets and liabilities -
Accounts receivable, net	(316,362)	(1,726,035)
Inventories, net	(256,005)	120,206
Prepaid expenses	40,176	(94,215)
Accounts payable	(737,086)	410,073
Customer advances	290,235	482,693
Accrued compensation and other	(106,789)	588,976
Net cash (used in) provided by operating activities	(1,706,998)	526,406
Cash Flows from Investing Activities:
Purchases of fixed assets	(260,804)	(20,010)
Additional patent costs	(21,274)	(32,401)
Net cash used in investing activities	(282,078)	(52,411)
Cash Flows from Financing Activities:
Payments of capital lease obligations	(32,164)	(30,298)
Payments of long-term debt	(384,945)	(275,784)
Payment of acquisition earn-out liability	0	(166,667)
Borrowings on revolving line of credit	400,000	0
Gross proceeds from the exercise of stock options	5,400	5,100
Net cash used in financing activities	(11,709)	(467,649)
Net (decrease) increase in cash and cash equivalents	(2,000,785)	6,346
Cash and cash equivalents, beginning of period	2,925,852	605,749
Cash and cash equivalents, end of period	$ 925,067	$ 612,095